tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

EPRX Stock Latest News

Eupraxia Pharmaceuticals Reports Strong Q4 2024 Results and Operational Progress
Company AnnouncementsEupraxia Pharmaceuticals Reports Strong Q4 2024 Results and Operational Progress
1M ago
EPRX
Eupraxia Pharmaceuticals reports FY24 EPS (76c), consensus (63c)
PremiumThe Fly
Eupraxia Pharmaceuticals reports FY24 EPS (76c), consensus (63c)
1M ago
EPRX
Eupraxia Pharmaceuticals management to meet virtually with Craig-Hallum
PremiumThe Fly
Eupraxia Pharmaceuticals management to meet virtually with Craig-Hallum
2M ago
EPRX
Eupraxia Pharmaceuticals Reports Promising Trial Results for Eosinophilic Esophagitis Treatment
PremiumCompany Announcements
Eupraxia Pharmaceuticals Reports Promising Trial Results for Eosinophilic Esophagitis Treatment
2M ago
EPRX
Eupraxia Pharmaceuticals’ EP-104GI shows efficacy in esophagitis trial
PremiumThe Fly
Eupraxia Pharmaceuticals’ EP-104GI shows efficacy in esophagitis trial
2M ago
EPRX
Craig-Hallum starts Eupraxia at Buy, sees ‘significant upside’ potential
PremiumThe FlyCraig-Hallum starts Eupraxia at Buy, sees ‘significant upside’ potential
2M ago
EPRX
Eupraxia Pharmaceuticals initiated with a Buy at Craig-Hallum
Premium
The Fly
Eupraxia Pharmaceuticals initiated with a Buy at Craig-Hallum
2M ago
EPRX
Eupraxia Pharmaceuticals Announces CFO Succession Amid Strategic Advancements
Premium
Company Announcements
Eupraxia Pharmaceuticals Announces CFO Succession Amid Strategic Advancements
2M ago
6K
EPRX
Eupraxia Pharmaceuticals announces CFO succession
PremiumThe Fly
Eupraxia Pharmaceuticals announces CFO succession
2M ago
EPRX
Eupraxia Pharmaceuticals Unveils Promising Drug Delivery Data
PremiumCompany Announcements
Eupraxia Pharmaceuticals Unveils Promising Drug Delivery Data
5M ago
EPRX
Eupraxia presents new PK data from its Phase 2a Eosinophilic Esophagitis program
PremiumThe Fly
Eupraxia presents new PK data from its Phase 2a Eosinophilic Esophagitis program
5M ago
EPRX
Eupraxia Pharmaceuticals Showcases Innovation at ACR 2024
PremiumCompany Announcements
Eupraxia Pharmaceuticals Showcases Innovation at ACR 2024
5M ago
EPRX
Eupraxia Pharmaceuticals initiated with a Buy at Rodman & Renshaw
PremiumThe FlyEupraxia Pharmaceuticals initiated with a Buy at Rodman & Renshaw
5M ago
EPRX
Eupraxia Pharmaceuticals initiated with a Buy at Rodman & Renshaw
Premium
The Fly
Eupraxia Pharmaceuticals initiated with a Buy at Rodman & Renshaw
5M ago
EPRX
Eupraxia Pharmaceuticals Hosts Webinar on Digestive Disorders
Premium
Company Announcements
Eupraxia Pharmaceuticals Hosts Webinar on Digestive Disorders
5M ago
EPRX
Eupraxia Pharmaceuticals Reports Promising Trial Results
PremiumCompany Announcements
Eupraxia Pharmaceuticals Reports Promising Trial Results
5M ago
EPRX
Eupraxia reports data from RESOLVE Phase 1b/2a trial
PremiumThe Fly
Eupraxia reports data from RESOLVE Phase 1b/2a trial
5M ago
EPRX
Eupraxia Pharmaceuticals Reports Q3 Progress and Funding
PremiumCompany Announcements
Eupraxia Pharmaceuticals Reports Q3 Progress and Funding
5M ago
EPRX
EPRX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
EPRX Upcoming Earnings Report: What to Expect?
6M ago
EPRX
Eupraxia Pharmaceuticals Secures C$44.5 Million Investment
PremiumCompany AnnouncementsEupraxia Pharmaceuticals Secures C$44.5 Million Investment
6M ago
EPRX
Eupraxia Pharmaceuticals Showcases Innovations in Drug Delivery
Premium
Company Announcements
Eupraxia Pharmaceuticals Showcases Innovations in Drug Delivery
6M ago
6K
EPRX
Eupraxia’s EP-104IAR Gains Attention in Rheumatology
Premium
Company Announcements
Eupraxia’s EP-104IAR Gains Attention in Rheumatology
6M ago
EPRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >